Русский

Pharmaceutical Industry Information Portal

News Feed

Drug manufacturers

Roche offers molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants

Ekaterina -
Roche and TIB Molbiol, a subsidiary within the Roche Diagnostics division, announced available testing solutions that can identify the...

Italian Stevanato Group expands the boundaries by opening a manufacturing hub in China

Ekaterina -
The company Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology...

illumina launches multiple-gene test to spot rare treatable cancers

Ekaterina -
Illumina, Inc. today announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor...

Regulatory News

MicroGEM’s PCR test, which gives results in 27 minutes, received EUA approval from FDA

Ekaterina -
MicroGEM has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the MicroGEM...

Sun Pharma shares up 4% after FDA approves mesalamine capsules

Ekaterina -
Sun Pharmaceutical Industries Limited, announced that it has received final approval from US FDA for its Abbreviated New Drug...

Lupin receives two FDA approvals and share price jumps

Ekaterina -
Global pharma major Lupin Ltd, May 06th, announced that it has received approval from the United States Food and...

World Pharma News

Valneva shares drop 20% after deal with EU on COVID vaccine is broken

Ekaterina -
Shares of Valneva plunged 20% on Monday after the French drugmaker said its COVID-19 vaccine agreement with the European...

MicroGEM’s PCR test, which gives results in 27 minutes, received EUA approval from FDA

Ekaterina -
MicroGEM has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the MicroGEM...

Inventiva raises €50 million credit line from the European Investment Bank

Ekaterina -
Inventiva, a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients...

Don’t miss your daily PharmProm news.
SUBSCRIBE free here!

SUBSCRIBE

Expert Articles

Combination of biomarkers discovered that can to identify subcortical small-vessel disease

Ekaterina -
In recent years, subcortical small-vessel disease has become an increasingly common cognitive diagnosis. Researchers at University of Gothenburg have...

New technologies are an integral part of diabetes management

Ekaterina -
A large population of people living with type 1 diabetes are set to be offered new technology to help...

EMA recommends approval of Spikevax for children aged 6 to 11

Ekaterina -
EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Spikevax to include...

Research and Development

MicroGEM’s PCR test, which gives results in 27 minutes, received EUA approval from FDA

Ekaterina -
MicroGEM has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the MicroGEM...

Yale, JDRF and NexImmune, $600,000 grant for diabetes research

Ekaterina -
NexImmune, Inc., Yale and JDRF have begun a two-year project to explore the use of NexImmune’s AIM nanoparticles in...

FDA lifts ban on LogicBio’s clinical trial on pediatric patients with methylmalonic acidemia

Ekaterina -
LogicBio Therapeutics, Inc., a clinical-stage company advancing a diversified pipeline of genetic medicines addressing rare disorders from infancy through...

Market analytics

Sales of AstraZeneca’s COVID vaccine exceed forecasts Q1 revenue $11.39 billion

Ekaterina -
AstraZeneca PLC said Friday that it expects sales of total revenue from COVID-19 medicines is anticipated to decline by...

Novo Nordisk raises 2022 outlook after strong quarter, shares up

Ekaterina -
Novo Nordisk targets higher sales and operating profit for the year on the back of projected profit growth in...

GSK shows strong sales performance in the first quarter of 2022 – £9.8 billion

Ekaterina -
British pharmaceutical giant GSK (GSK.L) on Wednesday beat analysts' expectations for its first-quarter results and reaffirmed its 2022 forecast. Highlights Strong...

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories